Moderna | MRNA - Equity Capital And Reserves


Moderna reported $6.76B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 1.31B 58.54M Jun/2026
Agios Pharmaceuticals USD 1.03B 83.09M Jun/2026
Alnylam Pharmaceuticals USD 1.35B 278.74M Jun/2026
Amgen USD 11.69B 2.5B Jun/2026
Arrowhead Research USD 465.53M 148.45M Jun/2026
Biogen USD 18.85B 196.3M Jun/2026
BioMarin Pharmaceutical USD 6.32B 109.58M Jun/2026
Celltrion KRW 434.82B 1.14B Mar/2026
Cspc Pharmaceutical CNY 33.18B 71.46M Dec/2025
Deva Holding AS TRY 5.79B 604.07M Sep/2023
Dianthus Therapeutics USD 1.17B 29.29M Jun/2026
Divis Laboratories Ltd INR 167.61B 13.48B Mar/2026
Gilead Sciences USD 11.74B 11.77B Jun/2026
GlaxoSmithKline GBP 17.64B 223M Jun/2026
Incyte USD 6.34B 721.58M Jun/2026
Ionis Pharmaceuticals USD 439.74M 51.68M Jun/2026
Kangmei Pharma CNY 7.31B 84.82M Mar/2026
Knight Therapeutics CAD 767.27M 480K Dec/2025
Laboratorios Farma EUR 539.39M 22.74M Dec/2023
Malin Corporation EUR 193.2M 75M Dec/2024
Moderna USD 6.76B 647M Jun/2026
Organigram Holdings CAD 371.81M 2.36M Mar/2026
Ovoca Bio EUR 780K 485K Dec/2025
Pharma Mar EUR 250.77M 1.1M Jun/2026
Puma Biotechnology USD 115.27M 10.55M Sep/2025
Qiagen NV USD 3.36B 26.03M Jun/2026
Regeneron Pharmaceuticals USD 31.71B 287.8M Jun/2026
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
Sarepta Therapeutics USD 1.53B 22.7M Jun/2026
Sartorius EUR 2.82B 96.3M Jun/2026
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
Tilray USD 1.58B 39.08M Sep/2025
Ultragenyx Pharmaceutical USD -291M 55M Jun/2026
United Therapeutics USD 6.4B 499.2M Jun/2026
Vertex Pharmaceuticals USD 20.25B 886M Jun/2026
Zealand Pharma A/S 14.47B 361.61M Mar/2026
Zz Pientze Pharmaceu CNY 15.21B 740.32M Mar/2026